Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests

12Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

The COVID-19 pandemic has resulted in an unprecedented global demand for in vitro diagnostic reagents. Supply shortages and hoarding have impacted testing capacity which has led to inefficient COVID-19 case identification and transmission control, predominantly in developing countries. Traditionally, RNA extraction is a prerequisite for conducting SARS-CoV-2 nucleic acid amplification tests (NAAT); however, simplified methods of sample processing have been success-ful at bypassing typical nucleic acid extraction steps, enabling extraction-free SARS-CoV-2 NAAT workflows. These methods involve chemical and physical approaches that are inexpensive and easily accessible alternatives to overcome extraction kit supply shortages, while offering acceptable test performance. Here we provide an overview of three main sample preparation strategies that have been shown to facilitate extraction-free SARS-CoV-2 NAATs.

Cite

CITATION STYLE

APA

Delgado-Diaz, D. J., Sakthivel, D., Nguyen, H. H. T., Farrokzhad, K., Hopper, W., Narh, C. A., & Richards, J. S. (2022, June 1). Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests. Viruses. MDPI. https://doi.org/10.3390/v14061311

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free